The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $440,350 in first-year total cost, median $220,175.
Most frequent study sections
- Gastrointestinal Mucosal Pathobiology Study Section[GMPB]1
- Special Emphasis Panel[ZDK1 GRB-G (O5)]1
Most frequent institutions
- MAYO CLINIC ROCHESTER1
- VETERANS MEDICAL RESEARCH FDN/SAN DIEGO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Phase 1/2 Trial of Indomethacin in Chronic Pancreatitis (The PAIR Trial)1R21DK117212-01A1 | VEGE, SANTHI SWAROOP | MAYO CLINIC ROCHESTER, MN | $226,600 | ZDK1 |
| 2019 | High Dimensional Mass Cytometry Analysis of the Effects of Vedolizumab in Intestinal Cellular Subsets and its Correlation with Clinical Parameters1R21DK118927-01A1 | RIVERA-NIEVES, JESUS | VETERANS MEDICAL RESEARCH FDN/SAN DIEGO, CA | $213,750 | GMPB |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.